The Tosoh HPLC-723G11 automatic HbA1c analyzer is a modern medical device that uses high-pressure liquid chromatography (HPLC) technology to accurately and quickly measure the concentration of HbA1c in the blood. HbA1c is an important indicator that reflects the average level of blood sugar control over 3 months, helping to diagnose and monitor the effectiveness of diabetes treatment.

With a compact design, easy to operate and maintain, the Tosoh HPLC-723G11 offers outstanding performance, meeting the testing needs of clinics, hospitals and medical centers. The machine is capable of analyzing up to 60 samples/hour, giving the first result in just 2 minutes from start-up, helping to optimize the workflow and save waiting time for customers.

The fully automated immunoassay analyzer VIDAS 3 from Biomérieux (France) is an automated immunoassay system designed for use in small and medium-sized laboratories with the advantage of saving floor space and no need for a drain.

VIDAS 3 uses proven ELFA (Enzyme Linked Fluorescent Assay) technology to provide accurate and reliable test results. The system is equipped with automation, flexibility, traceability, and continuous access, so it is also more productive.

DNBSEQ-G50 is a compact and versatile next-generation sequencing (NGS) system developed by MGI Tech Co., Ltd. (MGI). It uses proprietary DNBSEQ™ technology, combined with a dual-color optical system, to deliver high-performance sequencing at a reasonable cost. DNBSEQ-G50 is designed to meet a wide range of sequencing needs, from small-scale research projects to clinical applications that require high speed and accuracy.

MGI's DNBSEQ™ technology uses a unique library preparation process to generate DNBs (DNA nanoballs) that carry genetic information. These DNBs are then sequenced using a sequential synthesis method combined with high-resolution fluorescence imaging. As a result, DNBSEQ-G50 can generate high-quality sequencing data with outstanding accuracy and reliability.

The NextSeq 550 Next Generation Sequencing System is a powerful and versatile next-generation sequencing (NGS) system developed by Illumina, a leading biotechnology company. It uses Illumina's proprietary sequencing by synthesis (SBS) technology, enabling simultaneous reading of millions of DNA fragments with high accuracy. The NextSeq 550 is designed to meet the needs of a wide range of applications, from basic research to clinical diagnostics. The NextSeq 550 offers users many benefits thanks to its versatility and high performance. It can perform a variety of sequencing applications, including whole-exome sequencing, whole-genome sequencing, RNA sequencing, and targeted sequencing. The NextSeq 550 also allows users to customize sequencing capacity, from 16Gb to 400Gb per run, to suit project size and budget.

The FilmArray® testing system is a fully enclosed, multiparameter molecular testing system that provides rapid and accurate results for a wide range of infectious diseases. The system uses multiplex PCR (polymerase chain reaction) technology to simultaneously detect and identify a variety of pathogens, including bacteria, viruses, fungi and parasites, from a single specimen. With a simple and easy-to-use process, FilmArray® reduces sample processing time and provides rapid diagnostic results, supporting physicians in making timely and effective treatment decisions. The system is particularly useful in severe infections such as sepsis, meningitis and pneumonia, where rapid diagnosis is critical.